Socioeconomic status and the quality of prescribing asthma drugs in Sweden

References

• GINA. 2004 Update: workshop report, global strategy for asthma management and prevention: from the global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) 2004; 2004
   Google Scholar
• Stallberg B, Lisspers K, Hasselgren M, Janson C, Johansson G, Svardsudd K. Asthma control in primary care in Sweden: a comparison between 2001 and 2005. Prim Care Respir J 2009;18:279–286
   PubMedGoogle Scholar
• Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836–844
   PubMed Web of Science ®Google Scholar
• Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007;101:2437–2446
   PubMed Web of Science ®Google Scholar
• Davidsen JR, Sondergaard J, Hallas J, Siersted HC, Knudsen TB, Lykkegaard J, Andersen M. Impact of socioeconomic status on the use of inhaled corticosteroids in young adult asthmatics. Respir Med 2011;105:683–690
   PubMed Web of Science ®Google Scholar
• Haider SI, Johnell K, Ringback Weitoft G, Thorslund M, Fastbom J. Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. Eur J Clin Pharmacol 2008;64:1215–1222
   PubMed Web of Science ®Google Scholar
• Karlamangla AS, Singer BH, Williams DR, Schwartz JE, Matthews KA, Kiefe CI, Seeman TE. Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: the CARDIA Study (USA). Soc Sci Med 2005;60:999–1015
   PubMed Web of Science ®Google Scholar
• Greenwood HL, Edwards N, Hoogbruin A, Kahwa EK, Odhiambo ON, Buong JA. A review of equity issues in quantitative studies on health inequalities: the case of asthma in adults. BMC Med Res Methodol 2011;11:104
   PubMed Web of Science ®Google Scholar
• Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis 2012;6:11–23
   PubMed Web of Science ®Google Scholar
• Weitoft G, Rosén M, Ericsson O, Ljung R. Education and drug use in Sweden–a nationwide register-based study. Pharmacoepidemiol Drug Saf 2008;17:1020–1028
   PubMed Web of Science ®Google Scholar
• Arnlind MH, Nokela M, Rehnberg C, Jonsson EW. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 2006;43:585–591
   PubMed Web of Science ®Google Scholar
• Arnlind MH, Wettermark B, Nokela M, Hjemdahl P, Rehnberg C, Jonsson EW. Regional variation and adherence to guidelines for drug treatment of asthma. Eur J Clin Pharmacol 2010;66:187–198
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–667
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–735
   PubMed Web of Science ®Google Scholar
• Methodology WCCfDS. Guidelines for ATC classification and DDD assignment, 2012. Oslo 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2012. Available from: http://www.whocc.no [Last accessed 31 Oct 2012]
   Google Scholar
• Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000;29:495–502
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Lundholm C, Wettermark B, Ludvigsson JF, Ye W, Almqvist C. Validation of asthma and eczema in population-based Swedish drug and patient registers. Pharmacoepidemiol Drug Saf 2013 [Epub ahead of print]
   Google Scholar
• Hallas J, Stovring H. Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol 2006;98:260–265
   PubMed Web of Science ®Google Scholar
• Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, Sheffer A. GINA guidelines on asthma and beyond. Allergy 2007;62:102–112
   PubMed Web of Science ®Google Scholar
• Läkemedelsverket. Farmakologisk behandling vid astma-2007: (18)Temanummer. 2007
   Google Scholar
• Campbell S, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Oual Saf Health Care 2002;11:358–364
   PubMed Web of Science ®Google Scholar
• Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010;65:152–167
   PubMed Web of Science ®Google Scholar
• Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med 1998;157:123–128
   PubMed Web of Science ®Google Scholar
• Weiner P, Magadle R, Massarwa F, Beckerman M, Berar-Yanay N. Influence of gender and inspiratory muscle training on the perception of dyspnea in patients with asthma. Chest 2002;122:197–201
   PubMed Web of Science ®Google Scholar
• Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, Blanc PD. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J 2001;17:233–240
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Wenzel S. U.S. and European severe asthma cohorts: what can they teach us about severe asthma? J Intern Med 2012;272:121–132
   PubMed Web of Science ®Google Scholar
• Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev 2005;19:CD005535
   Google Scholar
• Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008;3:CD006363
   Google Scholar
• Beasley R, Martinez FD, Hackshaw A, Rabe KF, Sterk PJ, Djukanovic R. Safety of long-acting beta-agonists: urgent need to clear the air remains. Eur Respir J 2009;33:3–5
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Wall AJ, Buckley NS. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Am J Med 2010;123:322–328.e2
   PubMed Web of Science ®Google Scholar
• Ringbäck Weitoft G, Rosén M, Ericsson O, Ljung R. Education and drug use in Sweden – a nationwide register-based study. Pharmacoepidemiol Drug Saf 2008;17:1020–1028
   PubMed Web of Science ®Google Scholar
• Strom BL, Kimmel SE, Hennessy S. Pharmacoepidemiology. 5th ed. New York: Wiley-Blackwell; 2012
   Google Scholar